Category: Case Study

Moving Beyond the Static: The Future of Patient Outcomes In eye care, we’ve long managed the delicate dance between the accommodative and vergence systems. But are we doing enough for our symptomatic patients? New data from a retrospective analysis of 96,000+ patients suggests it’s time to move beyond traditional, static corrections. The results of transitioning…

A new learning experience is on its way. Built for your practice, your team, and the way you work. On-demand training, structured when you need it and flexible when you don’t. Built for running an independent clinic.   This June, mydryeye and Eye Care Edge Academy (ECEA) get a significant upgrade.  We've rebuilt the mydryeye portal and Eye Edge Care Academy from the ground up, designing it around…

Dr. Julian Prosia and JonPaul Prosia founded Ophthalogix Canada to bring dry eye treatments and cutting-edge amniotic membrane therapies to Canadian eye care professionals with full Health Canada approval. Amniotic membrane products have been available in the USA since 2015 with FDA approval, and now Canada is establishing a strong market presence for these highly effective, non-surgical corneal treatments. The Canadian…

Dry eye disease (DED) is one of the most prevalent and underdiagnosed conditions in eye care. With increased screen time, aging populations, and environmental stressors, the demand for specialized eye care is growing rapidly. For eye care professionals, establishing a dry eye centre of excellence is not only a clinical opportunity, but also a strategic…

Dry eye disease (DED) is a chronic, multifactorial condition that requires consistent management to achieve symptom relief and long-term ocular surface stability. Yet one of the biggest challenges eye care professionals face isn't the complexity of the disease. It's patient compliance. Despite the availability of effective therapies, many patients fail to follow their prescribed regimens.…